EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Association of Clonal Hematopoiesis With Incident, Late‐Onset, Seropositive Rheumatoid Arthritis

Kun Zhao, Yash Pershad, J Brett Heimlich, Michelle Ormseth iD, C Michael Stein, Brian Sharber, Caitlyn Vlasschaert, Alexander G Bick, Robert W Corty iD

Arthritis & Rheumatology · 2026-10 · 78 (10) · 2063-2073

DOI: 10.1002/art.70133 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arthritis & Rheumatology, online erschienen am 16.04.2026. Verfasst von Kun Zhao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Genetic Medicine and Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Clonal Hematopoiesis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, CSRD VA, Arthritis National Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Clonal hematopoiesis (CH), defined by acquired driver mutations in hematopoietic stem cells, is associated with many inflammatory diseases of aging. We investigated whether CH and its subtypes, CH of indeterminate potential (CHIP) and mosaic chromosomal alteration (mCA), are associated with incident rheumatoid arthritis (RA) and whether complement modifies these associations.

Methods

CHIP was detected in NIH All of Us, Vanderbilt BioVU, and UK Biobank; mCA was detected in UK Biobank. A harmonized, high‐specificity phenotyping algorithm was applied across biobanks to identify participants with seropositive and seronegative RA (SPRA and SNRA). Age‐scale survival models assessed the effect of CH on risk of incident RA. Effect modification was tested with interaction models with genetically predicted complement protein levels.

Results

Among 612,989 participants, 30,840 had CHIP, 1,535 had incident SPRA, and 1,090 had incident SNRA. CHIP was associated with an increased risk of incident SPRA (pooled hazard ratio [HR] 1.26; confidence interval [CI] 1.03–1.52; P = 2.3 × 10 −2 ), driven primarily by DNMT3A ‐mutated CHIP and late‐onset RA (HR 1.45; CI 1.13–1.96; P = 3.6 × 10 −3 ) but not SNRA. Autosomal mCA and mosaic loss of chromosome Y (mLOY) were associated with an increased risk of incident SPRA (HR 2.12 and 2.85; CI 1.18–3.8 and 1.57–5.19; P = 1.2 × 10 −2 and 6.1 × 10 −4 ) but not SNRA. Higher genetically predicted levels of C1r and C1s attenuated the CHIP–SPRA association.

Conclusion

Age‐related CH, including DNMT3A ‐CHIP, autosomal mCA, and mLOY, are risk factors for incident SPRA but not SNRA, supporting a genotype‐ and serostatus‐specific link between somatic mutation and RA, with the classical complement pathway as a potential modifier. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidClonal HematopoiesisHumansFemaleDNA Methyltransferase 3AMaleAgedMiddle AgedDNA (Cytosine-5-)-MethyltransferasesIncidenceAge of OnsetMosaicismComplement System ProteinsChromosome Aberrations

Substanzen

DNA Methyltransferase 3ADNA (Cytosine-5-)-MethyltransferasesDNMT3A protein, humanComplement System Proteins

Autor:innen und Institutionen

  • Division of Genetic Medicine and Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Division of Rheumatology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Department of Medicine, Queen's University, Kingston, Ontario, Canada.

ORCID-Profile: Michelle Ormseth, Robert W Corty

Förderung

  • NIH HHS
  • CSRD VA
  • Arthritis National Research Foundation
  • Rheumatology Research Foundation

Zitieren

APA

Zhao, K., Pershad, Y., Heimlich, J. B., Ormseth, M., Stein, C. M., Sharber, B., Vlasschaert, C., Bick, A. G., & Corty, R. W. (2026). Association of Clonal Hematopoiesis With Incident, Late‐Onset, Seropositive Rheumatoid Arthritis. Arthritis & Rheumatology, 78(10), 2063-2073. https://doi.org/10.1002/art.70133

Vancouver

Zhao K, Pershad Y, Heimlich JB, Ormseth M, Stein CM, Sharber B, et al. Association of Clonal Hematopoiesis With Incident, Late‐Onset, Seropositive Rheumatoid Arthritis. Arthritis & Rheumatology. 2026;78(10):2063-2073. doi:10.1002/art.70133

BibTeX
@article{Zhao2026,
  author = {Zhao, Kun and Pershad, Yash and Heimlich, J Brett and Ormseth, Michelle and Stein, C Michael and Sharber, Brian and Vlasschaert, Caitlyn and Bick, Alexander G and Corty, Robert W},
  title = {Association of Clonal Hematopoiesis With Incident, Late‐Onset, Seropositive Rheumatoid Arthritis},
  journal = {Arthritis & Rheumatology},
  year = {2026},
  volume = {78},
  number = {10},
  pages = {2063--2073},
  doi = {10.1002/art.70133}
}
Kostenlos starten →